| # | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. |  ALA2426097 | 26 | INH | = | 101 | % | ALA2427316 | % | Homo sapiens | |||
| 2. |  ALA2426072 | 58 | INH | = | 99 | % | ALA2427316 | % | Homo sapiens | |||
| 3. |  ALA2398350 | 6/7 | IC50 | > | 200 | uM | ALA2401362 | nM | Homo sapiens | |||
| 4. |  ALA2398351 | 9 | IC50 | = | 25.9 | uM | ALA2401362 | 4.59 | nM | Homo sapiens | ||
| 5. |  ALA2398352 | 11a/b | IC50 | = | 8.8 | uM | ALA2401362 | 5.06 | nM | Homo sapiens | ||
| 6. | ALA2398351 | 9 | INH | = | 126 | % | ALA2401360 | % | Homo sapiens | |||
| 7. |  PNU-120596 | PNU-120596 | %max | = | 103 | % | ALA3423810 | % | Homo sapiens | |||
| 8. |  conivaptan | Conivaptan | %max | = | 107 | % | ALA3423810 | % | Homo sapiens | |||
| 9. |  Regorafenib (BAY 73-4506) | 2, BAY-734506 | %max | = | 200 | % | ALA3423810 | % | Homo sapiens | |||
| 10. |  Telmisartan | Telmisartan | %max | = | 210 | % | ALA3423810 | % | Homo sapiens | |||
| 11. |  astemizole | 52 (Astemizole) | %max | = | 280 | % | ALA3423810 | % | Homo sapiens | |||
| 12. |  ALA416956 | Mefloquine | %max | = | 220 | % | ALA3423810 | % | Homo sapiens | |||
| 13. |  ALA46516 | 50 (Fluspirilene) | %max | = | 210 | % | ALA3423810 | % | Homo sapiens | |||
| 14. |  δ⁹-tetrahydrocannabinol | 3 | %max | = | 260 | % | ALA3423810 | % | Homo sapiens | |||
| 15. |  ALA1265 | Adapalene (CD 271) | %max | = | 260 | % | ALA3423810 | % | Homo sapiens | |||
| 16. |  Risperidone | Risperidone | %max | = | 190 | % | ALA3423810 | % | Homo sapiens | |||
| 17. |  Sulindac | sulindac | %max | = | 190 | % | ALA3423810 | % | Homo sapiens | |||
| 18. |  Dutasteride | 066 | %max | = | 200 | % | ALA3423810 | % | Homo sapiens | |||
| 19. |  Cinacalcet | SID50125742 | %max | = | 210 | % | ALA3423810 | % | Homo sapiens | |||
| 20. |  Cholecalciferol | in table 1 (Vitamin D 3) | %max | = | 220 | % | ALA3423810 | % | Homo sapiens |
The page will load shortly, Thanks for your patience!